WebDec 4, 2024 · An investigational stem cell-derived therapy for people with type 1 diabetes, developed by the Boston-based company Vertex Pharmaceuticals, has been shown to be effective at restoring insulin production in the first person to receive the therapy, according to a recent announcement from the company. The new therapy, known as VX-880, involves ... WebApr 13, 2024 · The Breakthrough Therapy designation for TTP399 in type 1 diabetes was supported by the recent positive results from the phase 2 SimpliciT-1 Study, a multi-center, randomized, double-blind ...
Melbourne researchers
WebOct 12, 2024 · A new procedure could help eliminate the need for insulin for some people with type 2 diabetes. The results of a clinical trial involving the new technique were unveiled today at a conference. The ... WebJun 12, 2024 · Scientists have also recently discovered a new treatment method that holds promise. A group of researchers from the University of Missouri, Georgia Institute of Technology, and Harvard University has proved the successful use of a novel Type 1 diabetes treatment in a large animal model in a new study published in Science … flowers greely ontario
WebDec 1, 2024 · Melton’s work has been a fascinating example of research aimed at using stem cells to create new insulin-producing cells in the body. Vertex had been focused largely on cystic fibrosis up until ... WebFeb 1, 2024 · Last week’s breakthrough news—that Vertex Pharmaceuticals will launch a clinical trial of VX-880, a stem cell-derived beta cell therapy in type 1 diabetes (T1D)—had its start in 2000. That’s when JDRF funded Douglas Melton, Ph.D., to make beta cells from stem cells. In 2014, he did it. Recognized by Science magazine as one of the top ... WebAug 9, 2024 · Alex Welsh for The New York Times. In the three decades since she was first diagnosed with Type 1 diabetes, Lisa Hepner has clung to a vague promise she often heard from doctors convinced medical ... green bay attorneys